Nova Capital Acquires BMP Group and RB Medical from Andrew Industries

Novi Labs Acquires RBN Energy

May 31, 2026

AI & Machine Learning

Novi Labs, an AI-driven energy intelligence company, announced the acquisition of RBN Energy, a Houston-based energy market intelligence, analytics, consulting, and education firm. The combined platform is intended to unify upstream forecasting and asset analytics with commodity market and midstream intelligence to provide a more complete view of energy asset economics across North America.

AMS Group Acquires BW Medical (medical accountancy practice)

September 24, 2025

Accounting & Tax

Manchester-headquartered AMS Group has acquired Newcastle-based BW Medical, a specialist accountancy practice serving healthcare professionals and GP practices across the UK. The deal brings roughly 30 staff (including three directors) into AMS, expanding its AMS Medical team to more than 100 people and strengthening its NHS pension, GP advisory and healthcare compliance capabilities.

Advanced Instruments (Patricia Industries) Completes Acquisition of Nova Biomedical

March 19, 2025

Healthcare Services

Advanced Instruments, a wholly owned subsidiary of Patricia Industries, completed its acquisition of Nova Biomedical for an enterprise value of USD 2.2 billion. The transaction followed regulatory approval and resulted in the combined business operating under the Nova Biomedical name, led by Advanced Instruments’ CEO Byron Selman.

R-V Industries (Prospect Capital portfolio) Acquires MBC Aerosol

March 4, 2022

Manufacturing

R-V Industries, a portfolio company of Prospect Capital Corporation, has acquired MBC Aerosol from its founders. MBC Aerosol will continue operations from its Elgin, Illinois facility with founders James McBride and Peter Burt remaining in place; the deal is an add-on to R-V's strategy of growth through acquisitions.

Novo Holdings Acquires BBI Group

June 15, 2021

Medical Devices

Novo Holdings A/S has agreed to acquire BBI Group from Exponent for an enterprise value of over GBP 400 million, becoming the company's majority shareholder. BBI, a Crumlin, South Wales–headquartered supplier of diagnostics reagents, lateral flow development and diagnostic manufacturing services with more than 400 employees, will benefit from Novo Holdings' life-sciences expertise to pursue organic and inorganic growth.

Novo Holdings Invests in Oxford Biomedica plc

May 28, 2019

Biotechnology

Novo Holdings A/S agreed to invest up to £53.5 million in new ordinary shares of Oxford Biomedica plc, taking up to a 10.1% stake. The proceeds will be used to repay an existing Oaktree debt facility in full and to scale Oxford Biomedica's LentiVector platform and proprietary product portfolio.